September 23, 2016

September 23, 2016

Cancer Research & Care
WFLA - Sept. 22
Governor Rick Scott is in the bay area for a very important announcement. The governor very proudly telling us the cancer center has been awarded the national cancer institute's highest designation comprehensive cancer center. only 4% of cancer research institutes in the united states have that designation. it means they are one of the most elite cancer treatment centers in the country.

Moffitt receives top designation
Fox 13 – Sept. 22
Tampa's Moffitt Cancer Center just got big pat on back and lot of cash with it. Governor Rick Scott was in town for this big announcement. national cancer institute just renewed its designation as a comprehensive cancer center, the highest designation Moffitt can get.

El Gobernador de estado en el Moffitt
Univision Orlando – Sept. 22
El gobernador de estado, rick scott, haga un anuncio que ayudara en la investacion del cancer.. el anuncio se esta llevando a cabo, en el Moffitt cancer Center, de Tampa.

Amid cancer research push, Moffitt receives top designation
Tampa Bay Times – Sept. 22
Moffitt Cancer Center has once again been awarded the National Cancer Institute's top title, Moffitt officials announced Thursday.

Moffitt Cancer Center, Governor Rick Scott Announce National Cancer Institute Designation
Tampa Patch – Sept. 22
Moffitt Cancer Center and Florida Governor Rick Scott announced today that the cancer center has been awarded the National Cancer Institute’s highest designation – Comprehensive Cancer Center. 

Moffitt Cancer Center announces National Cancer Institute Designation
Florida Trend – Sept. 22
Today, Gov. Rick Scott announced that the Moffitt Cancer Center has been awarded the National Cancer Institute’s highest designation – Comprehensive Cancer Center. Only four percent of cancer research institutions in the United States have received this prestigious designation. Moffitt is the only National Cancer Institute Comprehensive Cancer Center based in Florida.

Tampa's Hope Lodge to benefit from Pasco County event
Tampa Bay Times – Sept. 22
Part of the proceeds will go to the lodge, a a short-term residential facility for family members whose loved ones are being treated at Moffitt Cancer Center and other area cancer centers.

Expert highlights progress, looks ahead in kidney cancer care
Cure – Sept. 21
Fishman, a medical oncologist at Moffitt Cancer Center, highlighted the most recent advances in the field of RCC during a recent lecture.

Florida Cancer Specialists, bringing the latest technology to Hernando
Hernando Sun – Sept. 21
Dr. Malhotra said he is seeing more local patients referred from Moffitt Cancer Center‎ in Tampa for treatment closer to home at Florida Cancer Specialists. Of course, it is a two-way street; Florida Cancer Specialists also refers patients to Moffitt, if needed.

The Healthy WAAY with Erin Dacy: New treatment for eye cancer
WAAY – Sept. 21
Now Sabrina  is in this operating room trying percutaneous hepatic perfusion or P.H.P. Doctor Jonathan Zager has done this procedure on about 60 patients.  He said, "I think it is a breakthrough treatment."

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases
News Medical – Sept. 21
Moffitt Cancer Center researchers hope to improve these survival rates following a new study in Annals of Oncology that shows novel immune and targeted therapies with radiation therapy improves the outcomes of patients with melanoma brain metastases over conventional chemotherapy.

HAPPENING TODAY: EXPERTS PARTICIPATE IN CLINICAL TRAILS POLICY FORUM 
SaintPetersBlog.com – Sept. 21
The American Cancer Society Action Network is hosting a policy forum focusing on research and clinical trials at from 8 a.m. to 10 a.m. in the Vincent A. Stabile Research Building at the Moffitt Cancer Center, 12902 Magnolia Drive in Tampa. 

Technology helps Moffitt Cancer Center overcome communication hurdles
Fierce Healthcare – Sept. 19
The Moffitt Cancer Center and Research Institute in Tampa, Florida, is one of many provider organizations nationwide deploying technology to help caregivers and patients clearly communicate when language proves to be a barrier.

For Good: USF partners with custom T-shirt company to raise funds for Moffitt
83 Degrees Media – Sept. 20
The custom T-shirt company will provide USF’s ‘Bulls Against Cancer’ campaign shirts. These shirts support Moffitt Cancer Center, raising cancer awareness and funds for research.

Biology of Bone Metastases in Patients With CRPC
OncLive – Sept. 19
Conor Lynch, PhD, an associate professor of Tumor Biology at Moffitt Cancer Center, discusses the biology of bone metastases in patients with castration-resistant prostate cancer.

Latest Assays Can Improve Prostate Cancer Workup
Renal and Urology News – Sept. 19
Michael A. Poch, MD, from the University of South Florida and Moffitt Cancer Center in Tampa, reviewed these new tools, which include the Prostate Health Index (PHI), Prolaris, 4KScore, Oncotype DX Prostate Cancer Assay, and Decipher Prostate Cancer Biopsy.

Moffitt Cancer Center names malignant hematology department chair
Healio – Sept. 18
Jeffrey E. Lancet, MD, has been named chair and program leader for the department of malignant hematology at Moffitt Cancer Center.

Dr. Frakes on Late Toxicities in HPV-Associated Oropharynx Squamous Cell Carcinoma
OncLive – Sept. 16
Jessica Frakes, MD, assistant member, Department of Radiation Oncology, Moffitt Cancer Center, discusses some of the late toxicities seen in patients with HPV-positive oropharynx squamous cell carcinoma.

Recent Trials of CAR-T Therapy
OncLive - Sept. 16
Frederick L. Locke, MD: The results of the phase I portion of that ZUMA-1 study have been released. Essentially, seven patients were treated, and that was enough to determine that the fludarabine and Cytoxan dosing and the number of CAR-T cells administered were safe.

Combining vaccines, chemopreventive agents leads to ‘exciting advances’ in breast cancer
Healio – Sept. 16
A novel approach to breast cancer prevention - vaccines - could reduce the adverse events associated with current chemopreventive strategies like tamoxifen, according to Brian Czerniecki, MD, PhD, chair of the department of breast oncology at Moffitt Cancer Center. 

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.